Valion Bio (VBIO) Return on Equity [ROE] (2021 - 2026)
Valion Bio (VBIO) posted Return on Equity [ROE] of -128.08% for Q2 2026, up 25.42 percentage points from -153.50% a year earlier.
Powered by 
Analysis
Valion Bio (VBIO) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Valion Bio's Return on Equity [ROE] came in at -91.85%, up 93.11 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a three-year change of +27.62 percentage points (FY2022 to FY2025).
- In prior years, Valion Bio's Return on Equity [ROE] was -184.96% in FY2024 (+43.73 pp), -228.68% in FY2023 (-109.22 pp) and -119.47% in FY2022.
- Quarterly Return on Equity [ROE] has run from a low of -265.48% in Q1 2024 to a high of -57.79% in Q1 2022 over five years.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2025, with a gain of 104.11 percentage points; the weakest was Q1 2023, with a drop of 168.00 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 4.66% |
| 10 | Valion Bio | 73,008.00 | -25.39 Mn | - | -231.87% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -231.87% |
| Mar 31, 2026 | -90.28% |
| Dec 31, 2025 | -77.93% |
| Sep 30, 2025 | -174.74% |
| Jun 30, 2025 | -153.38% |
| Mar 31, 2025 | -161.23% |
| Dec 31, 2024 | -166.51% |
| Sep 30, 2024 | -182.81% |
| Jun 30, 2024 | -212.80% |
| Mar 31, 2024 | -265.48% |
| Dec 31, 2023 | -176.46% |
| Sep 30, 2023 | -185.01% |
| Jun 30, 2023 | -217.09% |
| Mar 31, 2023 | -225.78% |
| Dec 31, 2022 | -214.81% |
| Sep 30, 2022 | -145.20% |
| Jun 30, 2022 | -91.07% |
| Mar 31, 2022 | -57.78% |
| Dec 31, 2021 | -164.57% |
API Access
Valion Bio Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();